Cargando…
Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis
BACKGROUND: Following Food and Drug Administration (FDA) approval, many drugs are prescribed for non-FDA-approved (“off-label”) uses. If substantial evidence supports the efficacy and safety of off-label indications, manufacturers can pursue formal FDA approval through supplemental new drug applicat...
Autores principales: | Wang, Bo, Franklin, Jessica M., Eddings, Wesley, Landon, Joan, Kesselheim, Aaron S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816295/ https://www.ncbi.nlm.nih.gov/pubmed/27032095 http://dx.doi.org/10.1371/journal.pone.0152195 |
Ejemplares similares
-
Physicians’ Trust in the FDA’s Use of Product-Specific Pathways for Generic Drug Approval
por: Kesselheim, Aaron S., et al.
Publicado: (2016) -
Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
por: Kesselheim, Aaron S, et al.
Publicado: (2015) -
Medicaid Consumers and Informed Decisionmaking
por: Greene, Jessica, et al.
Publicado: (2009) -
The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine
por: Wang, Bo, et al.
Publicado: (2017) -
Adolescent Decisionmaking: Still A Mystery
Publicado: (2010)